Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Finasteride negatively affects fish reproduction and gonadal development.

GPT-4 performs well on medical exams but still needs human doctors for critical thinking.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Palash basti improved PMOS symptoms in a 26-year-old woman.